We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.22B
AUM Growth
-$194M
(-3%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$18M |
| 2 |
Monro
MNRO
|
+$15.1M |
| 3 |
Dentsply Sirona
XRAY
|
+$14.8M |
| 4 |
Hubbell
HUBB
|
+$12.1M |
| 5 |
Northern Trust
NTRS
|
+$8.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$31.3M |
| 2 |
W.W. Grainger
GWW
|
+$26.8M |
| 3 |
Verizon
VZ
|
+$21.9M |
| 4 |
IPG Photonics
IPGP
|
+$18.2M |
| 5 |
Coherent Inc
COHR
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.36% |
| 2 | Healthcare | 17.82% |
| 3 | Technology | 14.53% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Labcorp
LH
$25.8B
| $2.89M | 0.05% |
21,819
-192
| -0.9% | -$23.5K |
2013 Q2
16 quarters
|
|
252
Home Depot
HD
$309B
| $2.86M | 0.05% |
18,668
+50
| +0.3% | +$7.67K |
2013 Q2
16 quarters
|
|
253
Digital Realty Trust
DLR
$65.3B
| $2.83M | 0.05% |
25,100
+75
| +0.3% | +$8.58K |
2013 Q2
16 quarters
|
|
254
Zimmer Biomet
ZBH
$18.1B
| $2.78M | 0.04% |
+22,338
| New | +$2.65M |
2017 Q2
0 quarters
|
|
255
Paychex
PAYX
$39.7B
| $2.75M | 0.04% |
48,379
+369
| +0.8% | +$21.7K |
2013 Q2
16 quarters
|
|
|
CTXS
256
DELISTED
Citrix Systems Inc
CTXS
| $2.68M | 0.04% |
33,670
+225
| +0.7% | +$18.6K |
2013 Q2
16 quarters
|
|
257
Amgen
AMGN
$234B
| $2.65M | 0.04% |
15,413
+675
| +5% | +$110K |
2013 Q2
16 quarters
|
|
258
O'Reilly Automotive
ORLY
$72.2B
| $2.57M | 0.04% |
176,325
+49,260
| +39% | +$804K |
2013 Q2
16 quarters
|
|
259
Abbott
ABT
$181B
| $2.51M | 0.04% |
51,660
-8,854
| -15% | -$401K |
2013 Q2
16 quarters
|
|
260
Qualcomm
QCOM
$184B
| $2.5M | 0.04% |
45,300
+6,110
| +16% | +$341K |
2013 Q2
16 quarters
|
|
|
ABB
261
DELISTED
ABB Ltd
ABB
| $2.39M | 0.04% |
95,892
| – | – |
2013 Q2
16 quarters
|
|
262
Coca-Cola
KO
$404B
| $2.33M | 0.04% |
52,020
+2,918
| +6% | +$129K |
2013 Q2
16 quarters
|
|
263
LKQ Corp
LKQ
$5.62B
| $2.28M | 0.04% |
69,330
+4,920
| +8% | +$152K |
2013 Q2
16 quarters
|
|
264
Ball Corp
BALL
$16.7B
| $2.28M | 0.04% |
54,040
-3,350
| -6% | -$132K |
2014 Q4
10 quarters
|
|
265
Smith & Nephew
SNN
$12.2B
| $2.27M | 0.04% |
65,000
+2,000
| +3% | +$67.7K |
2015 Q4
6 quarters
|
|
266
Tootsie Roll Industries
TR
$2.87B
| $2.25M | 0.04% |
84,112
-6,504
| -7% | -$181K |
2015 Q4
6 quarters
|
|
267
American Water Works
AWK
$26.8B
| $2.24M | 0.04% |
28,745
-50
| -0.2% | -$3.93K |
2015 Q3
7 quarters
|
|
268
Equinor
EQNR
$111B
| $2.14M | 0.03% |
129,550
| – | – |
2016 Q1
5 quarters
|
|
|
ANDV
269
DELISTED
Andeavor
ANDV
| $2.12M | 0.03% |
22,648
+309
| +1% | +$26.1K |
2016 Q4
2 quarters
|
|
270
Quest Diagnostics
DGX
$25.9B
| $2.1M | 0.03% |
18,900
| – | – |
2014 Q2
12 quarters
|
|
271
Clorox
CLX
$10.5B
| $2.04M | 0.03% |
15,300
-50
| -0.3% | -$6.75K |
2013 Q2
16 quarters
|
|
272
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $2.02M | 0.03% |
25,300
+8,000
| +46% | +$639K |
2016 Q2
4 quarters
|
|
273
Brown-Forman Class B
BF.B
$13.3B
| $1.96M | 0.03% |
62,966
+2,188
| +4% | +$68.7K |
2013 Q2
16 quarters
|
|
274
AbbVie
ABBV
$504B
| $1.89M | 0.03% |
26,112
+3,750
| +17% | +$252K |
2013 Q2
16 quarters
|
|
275
Walt Disney
DIS
$191B
| $1.89M | 0.03% |
17,744
+1,205
| +7% | +$132K |
2013 Q2
16 quarters
|
|
Similar funds
Boston Trust Walden's Q2 2017 Portfolio in Review
As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.
- Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
- Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
- Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
- Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
- Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
- Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
- Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.
Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.